Application 021029
- Type
- NDA
- Sponsor
- MERCK SHARP DOHME
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TEMODAR | TEMOZOLOMIDE | CAPSULE;ORAL | 5MG | Yes | No |
| 002 | TEMODAR | TEMOZOLOMIDE | CAPSULE;ORAL | 20MG | Yes | No |
| 003 | TEMODAR | TEMOZOLOMIDE | CAPSULE;ORAL | 100MG | Yes | No |
| 004 | TEMODAR | TEMOZOLOMIDE | CAPSULE;ORAL | 250MG | Yes | Yes |
| 005 | TEMODAR | TEMOZOLOMIDE | CAPSULE;ORAL | 140MG | Yes | No |
| 006 | TEMODAR | TEMOZOLOMIDE | CAPSULE;ORAL | 180MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021029-001 | TEMODAR | TEMOZOLOMIDE | 5MG | CAPSULE / ORAL | RLD | 1999-08-11 | |
| N021029-002 | TEMODAR | TEMOZOLOMIDE | 20MG | CAPSULE / ORAL | RLD | 1999-08-11 | |
| N021029-003 | TEMODAR | TEMOZOLOMIDE | 100MG | CAPSULE / ORAL | RLD | 1999-08-11 | |
| N021029-004 | TEMODAR | TEMOZOLOMIDE | 250MG | CAPSULE / ORAL | RLD | 1999-08-11 | |
| N021029-005 | TEMODAR | TEMOZOLOMIDE | 140MG | CAPSULE / ORAL | RLD | 2006-10-19 | |
| N021029-006 | TEMODAR | TEMOZOLOMIDE | 180MG | CAPSULE / ORAL | RLD | 2006-10-19 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021029-001 | TEMODAR | 5MG | CAPSULE / ORAL | RLD | 1999-08-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021029-002 | TEMODAR | 20MG | CAPSULE / ORAL | RLD | 1999-08-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021029-003 | TEMODAR | 100MG | CAPSULE / ORAL | RLD | 1999-08-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021029-004 | TEMODAR | 250MG | CAPSULE / ORAL | RLD | 1999-08-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021029-005 | TEMODAR | 140MG | CAPSULE / ORAL | RLD | 2006-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021029-006 | TEMODAR | 180MG | CAPSULE / ORAL | RLD | 2006-10-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021029-001 | TEMODAR | 5MG | CAPSULE / ORAL | RLD | 1999-08-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021029-002 | TEMODAR | 20MG | CAPSULE / ORAL | RLD | 1999-08-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021029-003 | TEMODAR | 100MG | CAPSULE / ORAL | RLD | 1999-08-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021029-004 | TEMODAR | 250MG | CAPSULE / ORAL | RLD | 1999-08-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021029-005 | TEMODAR | 140MG | CAPSULE / ORAL | RLD | 2006-10-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021029-006 | TEMODAR | 180MG | CAPSULE / ORAL | RLD | 2006-10-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021029-001 | TEMODAR | 5MG | CAPSULE / ORAL | RLD | 1999-08-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021029-002 | TEMODAR | 20MG | CAPSULE / ORAL | RLD | 1999-08-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021029-003 | TEMODAR | 100MG | CAPSULE / ORAL | RLD | 1999-08-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021029-004 | TEMODAR | 250MG | CAPSULE / ORAL | RLD | 1999-08-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021029-005 | TEMODAR | 140MG | CAPSULE / ORAL | RLD | 2006-10-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021029-006 | TEMODAR | 180MG | CAPSULE / ORAL | RLD | 2006-10-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021029-001 | TEMODAR | 5MG | CAPSULE / ORAL | RLD | 1999-08-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021029-002 | TEMODAR | 20MG | CAPSULE / ORAL | RLD | 1999-08-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021029-003 | TEMODAR | 100MG | CAPSULE / ORAL | RLD | 1999-08-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021029-004 | TEMODAR | 250MG | CAPSULE / ORAL | RLD | 1999-08-11 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021029-005 | TEMODAR | 140MG | CAPSULE / ORAL | RLD | 2006-10-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021029-006 | TEMODAR | 180MG | CAPSULE / ORAL | RLD | 2006-10-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021029-001 | TEMODAR | 5MG | CAPSULE / ORAL | RLD | 1999-08-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021029-002 | TEMODAR | 20MG | CAPSULE / ORAL | RLD | 1999-08-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021029-003 | TEMODAR | 100MG | CAPSULE / ORAL | RLD | 1999-08-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021029-004 | TEMODAR | 250MG | CAPSULE / ORAL | RLD | 1999-08-11 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021029-005 | TEMODAR | 140MG | CAPSULE / ORAL | RLD | 2006-10-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021029-006 | TEMODAR | 180MG | CAPSULE / ORAL | RLD | 2006-10-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021029-001 | TEMODAR | 5MG | CAPSULE / ORAL | RLD | 1999-08-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021029-002 | TEMODAR | 20MG | CAPSULE / ORAL | RLD | 1999-08-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021029-003 | TEMODAR | 100MG | CAPSULE / ORAL | RLD | 1999-08-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021029-004 | TEMODAR | 250MG | CAPSULE / ORAL | RLD | 1999-08-11 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021029-005 | TEMODAR | 140MG | CAPSULE / ORAL | RLD | 2006-10-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021029-006 | TEMODAR | 180MG | CAPSULE / ORAL | RLD | 2006-10-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021029-001 | TEMODAR | 5MG | CAPSULE / ORAL | RLD | 1999-08-11 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021029-002 | TEMODAR | 20MG | CAPSULE / ORAL | RLD | 1999-08-11 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021029-003 | TEMODAR | 100MG | CAPSULE / ORAL | RLD | 1999-08-11 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021029-004 | TEMODAR | 250MG | CAPSULE / ORAL | RLD | 1999-08-11 | 03ed91905a0d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021029-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021029-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021029-003 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021029-004 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021029-005 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021029-006 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021029-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N021029-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N021029-003 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N021029-004 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N021029-005 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N021029-006 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021029-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N021029-002 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N021029-003 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N021029-004 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N021029-005 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | N021029-006 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N021029-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021029-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021029-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021029-004 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021029-005 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021029-006 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021029-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N021029-002 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N021029-003 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N021029-004 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N021029-005 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | N021029-006 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N021029-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N021029-002 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N021029-003 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N021029-004 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N021029-005 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | N021029-006 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021029-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021029-002 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021029-003 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021029-004 | AB | 1 | 87673890dc5c… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TEMODAR | TEMOZOLOMIDE | Merck Sharp & Dohme LLC | 046a9011-3911-4d3f-a15f-fbb56d5aad56 | 2026-02-20 | Warnings, Adverse reactions | 021029 NDA021029 0085-1366 0085-3004 0085-1430 0085-1425 0085-1417 0085-1519 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0085-1366 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1366 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1366 | TEMODAR | Temozolomide | Merck Sharp & Dohme LLC | NDA | Current |
| 0085-1366 | TEMODAR | Temozolomide | Merck Sharp & Dohme LLC | NDA | Current |
| 0085-1366 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1366 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1417 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1417 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1417 | TEMODAR | Temozolomide | Merck Sharp & Dohme LLC | NDA | Current |
| 0085-1417 | TEMODAR | Temozolomide | Merck Sharp & Dohme LLC | NDA | Current |
| 0085-1417 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1417 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1425 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1425 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1425 | TEMODAR | Temozolomide | Merck Sharp & Dohme LLC | NDA | Current |
| 0085-1425 | TEMODAR | Temozolomide | Merck Sharp & Dohme LLC | NDA | Current |
| 0085-1425 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1425 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1430 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1430 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1430 | TEMODAR | Temozolomide | Merck Sharp & Dohme LLC | NDA | Current |
| 0085-1430 | TEMODAR | Temozolomide | Merck Sharp & Dohme LLC | NDA | Current |
| 0085-1430 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1430 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1519 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1519 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1519 | TEMODAR | Temozolomide | Merck Sharp & Dohme LLC | NDA | Current |
| 0085-1519 | TEMODAR | Temozolomide | Merck Sharp & Dohme LLC | NDA | Current |
| 0085-1519 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-1519 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-3004 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-3004 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-3004 | TEMODAR | Temozolomide | Merck Sharp & Dohme LLC | NDA | Current |
| 0085-3004 | TEMODAR | Temozolomide | Merck Sharp & Dohme LLC | NDA | Current |
| 0085-3004 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0085-3004 | TEMODAR | Temozolomide | Merck Sharp & Dohme Corp. | NDA | Current |
| 0781-2691 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2691 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2691 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2691 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2692 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2692 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2692 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2692 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2693 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2693 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2693 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2693 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2694 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2694 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2694 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2694 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2695 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2695 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2695 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2695 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2696 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2696 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2696 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
| 0781-2696 | Temozolomide | Temozolomide | Sandoz Inc. | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 75594 | SUPPL | 2023-09-28 |
| 75593 | SUPPL | 2023-09-28 |
| 75592 | SUPPL | 2023-09-28 |
| 75482 | SUPPL | 2023-09-15 |
| 75481 | SUPPL | 2023-09-15 |
| 75480 | SUPPL | 2023-09-15 |
| 75459 | SUPPL | 2023-09-14 |
| 75458 | SUPPL | 2023-09-14 |
| 75457 | SUPPL | 2023-09-14 |
| 65319 | SUPPL | 2020-11-25 |
| 65305 | SUPPL | 2020-11-25 |
| 61050 | SUPPL | 2019-11-26 |
| 61046 | SUPPL | 2019-11-25 |
| 50027 | SUPPL | 2017-10-12 |
| 49995 | SUPPL | 2017-10-10 |
| 47430 | SUPPL | 2017-03-02 |
| 47337 | SUPPL | 2017-02-27 |
| 14203 | SUPPL | 2016-02-18 |
| 26535 | SUPPL | 2016-02-16 |
| 14202 | SUPPL | 2015-09-23 |
| 4098 | SUPPL | 2015-09-22 |
| 35936 | SUPPL | 2015-04-07 |
| 26534 | SUPPL | 2015-04-03 |
| 35935 | SUPPL | 2014-05-06 |
| 26533 | SUPPL | 2014-05-06 |
| 35934 | SUPPL | 2013-01-09 |
| 4097 | SUPPL | 2011-06-09 |
| 14201 | SUPPL | 2011-06-07 |
| 14200 | SUPPL | 2011-02-09 |
| 26532 | SUPPL | 2010-04-29 |
| 35933 | SUPPL | 2010-04-28 |
| 35932 | SUPPL | 2006-10-23 |
| 4096 | SUPPL | 2006-10-23 |
| 4095 | SUPPL | 2006-04-07 |
| 4094 | SUPPL | 2005-04-28 |
| 26531 | SUPPL | 2005-03-31 |
| 4093 | SUPPL | 2005-03-18 |
| 14199 | SUPPL | 2005-03-15 |
| 26530 | SUPPL | 2004-07-21 |
| 4092 | SUPPL | 2004-06-30 |
| 41890 | SUPPL | 2004-04-14 |
| 35931 | SUPPL | 2003-03-26 |
| 26529 | SUPPL | 2003-03-26 |
| 26528 | SUPPL | 2002-01-18 |
| 14198 | SUPPL | 2002-01-18 |
| 41889 | ORIG | 1999-08-11 |
| 35930 | ORIG | 1999-08-11 |
| 26527 | ORIG | 1999-08-11 |
| 52217 | SUPPL | 1900-01-01 |
| 52216 | SUPPL | 1900-01-01 |
| 52215 | SUPPL | 1900-01-01 |
| 52214 | SUPPL | 1900-01-01 |
| 52213 | SUPPL | 1900-01-01 |